Final Glance: Biotechnology companies
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
Midday Glance: Biotechnology companies
AP - Thu Jul 31, 12:33PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Uptrend Call Working As Amgen Stock Rises 10.4% (AMGN)
Comtex SmarTrend(R) - Thu Jul 31, 11:22AM CDT
SmarTrend identified an Uptrend for Amgen (NASDAQ:AMGN) on June 2nd, 2014 at $116.45. In approximately 2 months, Amgen has returned 10.41% as of today's recent price of $128.57.
Early Glance: Biotechnology companies
AP - Thu Jul 31, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
Stock Market News for July 31, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 9:10AM CDT
Benchmarks ended Wednesday’s choppy trading session little changed after the Federal Reserve offered a mixed view on the economy
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.
RBCC 3D Bioprinting Partner Awarded Prestigious Grant
Business Wire - Thu Jul 31, 5:54AM CDT
The joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), moved significantly closer to its funding goals this week thanks to a prestigious research grant from the National Institutes of Health.
Asian markets drift after US Fed stays course
By KAY JOHNSON - AP - Wed Jul 30, 11:37PM CDT
MUMBAI, India (AP) — Asian stock markets were uninspired by an upbeat report on the U.S. economy, with most drifting lower Thursday after the U.S. Federal Reserve said it would make further cuts to its monetary stimulus as expected.
Amgen Set to Possibly Pullback After Yesterday's Rally of 5.43%
Comtex SmarTrend(R) - Wed Jul 30, 3:39PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $128.63 to a high of $131.24. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high of $124.39 on volume of 8.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion
at The Street - Wed Jul 30, 3:31PM CDT
Major U.S. stock markets are mixed on Wednesday as the Federal Reserve maintains its federal funds rate and cuts monthly bond buying by $10 billion to $25 billion.
Today's Trades: 3 Big Stocks Getting Big Attention
at The Street - Wed Jul 30, 1:18PM CDT
Here's how to trade some of the most active stocks on the market today.
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement
at The Street - Wed Jul 30, 12:50PM CDT
U.S. stocks slip on Wednesday as positive sentiment gives way to nerves ahead of the Federal Reserve's policy announcement.
Amgen Restructuring Plan, Q2 Earnings Send Stock Up
at Investor's Business Daily - Wed Jul 30, 10:20AM CDT
Amgen (AMGN) was up more than 5%, near 129, in early trading in the stock market today as analysts approved of big-cap biotech's earnings beat and restructuring plans announced late Tuesday. Earlier, Amgen stock touched a new high above 131. Amgen's...
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
at The Street - Wed Jul 30, 10:05AM CDT
Amgen's reallocation of resources is not quieting critics who want a bigger restructuring.
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain
Marketwire - Wed Jul 30, 9:00AM CDT
Resilinc Corp., the leading provider of supply chain resiliency solutions, today announced that it has been named a 2014 Great Supply Chain Partner by SupplyChainBrain. Resilinc was nominated by Amgen for its contributions to Amgen's global supply chain resiliency strategy as detailed in a recently published interactive case study. Resilinc will appear in the 2014 July/August issue of SupplyChainBrain magazine.
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 30, 8:20AM CDT
While Amgen's (AMGN) second quarter results were impressive, the company's restructuring plan remained in focus.